Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu's Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Giant cell arteritis; Takayasu syndrome
- Focus Therapeutic Use
- 31 Jan 2017 New trial record
- 30 Jan 2017 Results of patients with giant cell arteritis (n=49) published in the Arthritis and Rheumatology
- 30 Jan 2017 Results of patients with Takayasu's arteritis (n=34) published in the Arthritis and Rheumatology